This is the authors' abstract. We don't add key points for this paper.
Optimizing drug dosing in patients with inflammatory conditions requires an understanding of how inflammation impacts drug-metabolizing enzymes (DMEs), particularly the cytochrome P450 (CYP) sup...
No takes yet. Share an insight, caveat, or question.
El-Mahrouk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: